Literature DB >> 30641490

Kill painting of hypoxic tumors with multiple ion beams.

O Sokol1, M Krämer, S Hild, M Durante, E Scifoni.   

Abstract

We report on a novel method for simultaneous biological optimization of treatment plans for hypoxic tumors using multiple ion species. Our previously introduced kill painting approach, where the overall cell killing is optimized on biologically heterogeneous targets, was expanded with the capability of handling different ion beams simultaneously. The current version (MIBO) of the research treatment planning system TRiP98 has now been augmented to handle 3D (voxel-by-voxel) target oxygenation data. We present a case of idealized geometries where this method can identify optimal combinations leading to an improved peak-to-entrance effective dose ratio. This is achieved by the redistribution of particle fluences, when the heavier ions are preferentially forwarded to hypoxic target areas, while the lighter ions deliver the remaining dose to its normoxic regions. Finally, we present an in silico skull base chordoma patient case study with a combination of 4He and 16O beams, demonstrating specific indications for its potential clinical application. In this particular case, the mean dose, received by the brainstem, was reduced by 3%-5% and by 10%-12% as compared to the pure 4He and 16O plans, respectively. The new method allows a full biological optimization of different ion beams, exploiting the capabilities of actively scanned ion beams of modern particle therapy centers. The possible experimental verification of the present approach at ion beam facilities disposing of fast ion switch is presented and discussed.

Entities:  

Year:  2019        PMID: 30641490     DOI: 10.1088/1361-6560/aafe40

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  10 in total

1.  Post-Irradiation Recovery of B14-150 Fibrosarcoma Cells after Combined Irradiation with Low and High Linear Energy Transfer.

Authors:  E V Koryakina; V I Potetnya; M V Troshina; A N Solov'ev; V O Saburov; A A Lychagin; S N Koryakin; S A Ivanov; A D Kaprin
Journal:  Bull Exp Biol Med       Date:  2022-10-10       Impact factor: 0.737

Review 2.  Particle therapy in the future of precision therapy.

Authors:  Lukas Schaub; Semi Ben Harrabi; Juergen Debus
Journal:  Br J Radiol       Date:  2020-08-14       Impact factor: 3.629

3.  Physics and biomedical challenges of cancer therapy with accelerated heavy ions.

Authors:  Marco Durante; Jürgen Debus; Jay S Loeffler
Journal:  Nat Rev Phys       Date:  2021-09-17

4.  Three discipline collaborative radiation therapy (3DCRT) special debate: The United States needs at least one carbon ion facility.

Authors:  Eleanor A Blakely; Bruce Faddegon; Christopher Tinkle; Charles Bloch; Michael Dominello; Robert J Griffin; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.243

Review 5.  Hadrontherapy Interactions in Molecular and Cellular Biology.

Authors:  Juliette Thariat; Samuel Valable; Carine Laurent; Siamak Haghdoost; Elodie A Pérès; Myriam Bernaudin; François Sichel; Paul Lesueur; Mathieu Césaire; Edwige Petit; Aurélie E Ferré; Yannick Saintigny; Sven Skog; Mihaela Tudor; Michael Gérard; Sebastien Thureau; Jean-Louis Habrand; Jacques Balosso; François Chevalier
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

Review 6.  Carbon Ion Radiobiology.

Authors:  Walter Tinganelli; Marco Durante
Journal:  Cancers (Basel)       Date:  2020-10-17       Impact factor: 6.575

7.  Spot-Scanning Hadron Arc (SHArc) Therapy: A Study With Light and Heavy Ions.

Authors:  Stewart Mein; Thomas Tessonnier; Benedikt Kopp; Semi Harrabi; Amir Abdollahi; Jürgen Debus; Thomas Haberer; Andrea Mairani
Journal:  Adv Radiat Oncol       Date:  2021-02-04

8.  Including Volume Effects in Biological Treatment Plan Optimization for Carbon Ion Therapy: Generalized Equivalent Uniform Dose-Based Objective in TRiP98.

Authors:  Marco Battestini; Marco Schwarz; Michael Krämer; Emanuele Scifoni
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244

Review 9.  The Role of Cancer Stem Cells in Radiation Resistance.

Authors:  Christoph Reinhold Arnold; Julian Mangesius; Ira-Ida Skvortsova; Ute Ganswindt
Journal:  Front Oncol       Date:  2020-02-20       Impact factor: 6.244

Review 10.  Future Developments in Charged Particle Therapy: Improving Beam Delivery for Efficiency and Efficacy.

Authors:  Jacinta Yap; Andrea De Franco; Suzie Sheehy
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 5.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.